FDA NDC Directory · JSON-LD · Markdown

Levothyroxine Sodium

NDC 0615-8598 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerNCS HealthCare of KY, LLC dba Vangard Labs
Marketing categoryNew Drug Application (innovator) · App NDA021210
Dosage form / routeTABLET · ORAL
Active ingredientsLEVOTHYROXINE SODIUM (.088 mg/1)
Marketing started20031201
Package count4

External sources

Source: openFDA. Public-domain (CC0).